Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testosterone delivery using glutamide-based complex high axial ratio microstructures.

A S Goldstein1, J K Amory, S M Martin

  • 1Departments of Chemistry and Biochemistry, University of Washington, Box 351700, Seattle, WA 98195-1700, USA.

Bioorganic & Medicinal Chemistry
|October 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interactions between angiotensin II and norepinephrine on renin release by juxtaglomerular cells.

European journal of endocrinology·1995
Same author

Louisianins A, B, C and D: non-steroidal growth inhibitors of testosterone-responsive SC 115 cells. I. Taxonomy, fermentation, isolation and biological characteristics.

The Journal of antibiotics·1995
Same author

[Empyema caused by perforation of metastatic colon cancer: a case report].

Kyobu geka. The Japanese journal of thoracic surgery·1995
Same author

Morphologic alterations and cytokinetic studies of tracheal autograft epithelium in rabbits.

The Annals of thoracic surgery·1995
Same author

[Contributions of tumor types and stages on insulin resistance in patients with cancer: preliminary report].

Nihon Geka Gakkai zasshi·1995
Same author

[Mechanism of hyperinsulinemia in gastrectomized patients with oxyhyperglycemia: preliminary report].

Nihon Geka Gakkai zasshi·1995
Same journal

Transport specificity of FpvA and FpvB for pyoverdine-antibiotic conjugates in Pseudomonas aeruginosa.

Bioorganic & medicinal chemistry·2026
Same journal

Design and engineering of μO-conotoxin MfVIA mutants to enhance Na<sub>V</sub>1.8 inhibition and analgesic efficacy in inflammatory pain.

Bioorganic & medicinal chemistry·2026
Same journal

Recent advances in Camptothecin-derived antibody-drug conjugates.

Bioorganic & medicinal chemistry·2026
Same journal

CDK4/6-targeted therapy: From clinical inhibitors to emerging strategies to overcome resistance.

Bioorganic & medicinal chemistry·2026
Same journal

Coumarin-sulfonamide hybrids as PKM2 activators induce metabolic reprogramming and suppress ovarian cancer cell growth.

Bioorganic & medicinal chemistry·2026
Same journal

Recent advances in the development of small-molecule drugs based on covalent reversible inhibitors.

Bioorganic & medicinal chemistry·2026
See all related articles

Complex high axial ratio microstructures (CHARMs) effectively delivered testosterone in vivo. Testosterone-loaded CHARMs demonstrated biphasic release kinetics and sustained presence at the injection site in rats.

Area of Science:

  • Biomaterials Science
  • Drug Delivery Systems
  • Endocrinology

Background:

  • Complex high axial ratio microstructures (CHARMs) offer potential for controlled substance delivery.
  • Testosterone replacement therapy requires effective and sustained delivery methods.

Purpose of the Study:

  • To evaluate CHARMs for in vivo testosterone delivery.
  • To investigate methods for incorporating testosterone into CHARMs.
  • To characterize the release kinetics and in vivo persistence of testosterone from CHARMs.

Main Methods:

  • Testosterone was incorporated into CHARMs via noncovalent mixing or covalent attachment to form a prodrug monomer.
  • In vitro hydrolysis resistance of testosterone-loaded CHARMs was assessed.
  • In vivo testosterone release and pharmacokinetics were studied in rats following injection.

Related Experiment Videos

Main Results:

  • Covalently attached testosterone-loaded CHARMs exhibited resistance to in vitro hydrolysis.
  • In vivo administration resulted in biphasic testosterone release: an initial burst followed by a slow-release phase.
  • CHARM material remained at the injection site for at least 9 days.

Conclusions:

  • Testosterone-loaded CHARMs are a viable system for in vivo testosterone delivery.
  • Covalent attachment enhances the stability of testosterone within CHARMs.
  • The biphasic release profile and prolonged local persistence suggest potential for sustained testosterone therapy.